Nishan de Silva
2014
In 2014, Nishan de Silva earned a total compensation of $2.8M as Former VP, Finance and Strategy and Chief Financial Officer at Ligand Pharmaceuticals, a 149% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,360 |
|---|---|
| Option Awards | $2,156,661 |
| Salary | $300,547 |
| Stock Awards | $223,260 |
| Other | $5,700 |
| Total | $2,806,528 |
de Silva received $2.2M in option awards, accounting for 77% of the total pay in 2014.
de Silva also received $120.4K in non-equity incentive plan, $300.5K in salary, $223.3K in stock awards and $5.7K in other compensation.
Rankings
In 2014, Nishan de Silva's compensation ranked 3,242nd out of 13,032 executives tracked by ExecPay. In other words, de Silva earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,242 out of 13,032 | 75th |
Division Manufacturing | 1,150 out of 4,965 | 77th |
Major group Chemicals And Allied Products | 370 out of 1,690 | 78th |
Industry group Drugs | 288 out of 1,369 | 79th |
Industry Pharmaceutical Preparations | 236 out of 1,042 | 77th |
Source: SEC filing on April 12, 2016.
de Silva's colleagues
We found four more compensation records of executives who worked with Nishan de Silva at Ligand Pharmaceuticals in 2014.